These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 5973053)

  • 21. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Characteristics of contact activation of rabbit blood (kallikrein and plasmin systems].
    Komissarova NV; Gomazkov OA
    Biull Eksp Biol Med; 1976; 81(4):390-2. PubMed ID: 132208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New evidence for the activation of factor XII by epinephrine.
    Zubairov DM; Popova LG
    Thromb Res; 1976 May; 8(5):587-97. PubMed ID: 180627
    [No Abstract]   [Full Text] [Related]  

  • 24. Molecular heterogeneity of Hageman trait (factor XII deficiency): evidence that two of 49 subjects are cross-reacting material positive (CRM+).
    Saito H; Scott JG; Movat HZ; Scialla SJ
    J Lab Clin Med; 1979 Aug; 94(2):256-65. PubMed ID: 110893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chromatographic method of analyzing Hageman factor (blood coagulation factor XII) in human serum].
    Krizhevskaia IuV; Dotsenko VL; Iarovaia GA
    Vopr Med Khim; 1982; 28(2):128-32. PubMed ID: 7080474
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of expression of monocyte interleukin-1 by inhibitors of Hageman factor (factor XII).
    Ratnoff OD; Voytus JA; Toossi Z
    J Lab Clin Med; 1995 Feb; 125(2):247-50. PubMed ID: 7844472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator.
    Forbes CD; Pensky J; Ratnoff OD
    J Lab Clin Med; 1970 Nov; 76(5):809-15. PubMed ID: 5477337
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of heparin on the arginine (BAEE) esterase activity of blood.
    FLOCH MH; GROISSER VW
    J Pharmacol Exp Ther; 1962 Feb; 135():256-8. PubMed ID: 13893608
    [No Abstract]   [Full Text] [Related]  

  • 29. Activation of the Hageman factor-prekallikrein system in the pathogenesis of the generalized Shwartzman reaction and of the hepatic vein thrombosis phenomenon in the rat.
    Latour JG; Groulx C; Léger-Gauthier C
    Lab Invest; 1979 Sep; 41(3):237-46. PubMed ID: 470342
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of the activation of Hageman factor (factor XII) by extracts of Schistosoma mansoni.
    Foster CB; Flanigan TP; DeStigter KK; Blanton R; Dumenco LL; Gallagher C; Ratnoff OD
    J Lab Clin Med; 1992 Nov; 120(5):735-9. PubMed ID: 1431502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoquantitation of Hageman factor in urine and plasma of children with nephrotic syndrome.
    Hruby MA; Honig GR; Shapira E
    J Lab Clin Med; 1980 Sep; 96(3):501-10. PubMed ID: 6772722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.
    Goldsmith GH; Saito H; Ratnoff OS
    J Clin Invest; 1978 Jul; 62(1):54-60. PubMed ID: 659637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of Hageman factor by collagen.
    Wilner GD; Nossel HL; LeRoy EC
    J Clin Invest; 1968 Dec; 47(12):2608-15. PubMed ID: 4302176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arginine esterase in cystic fibrosis of the pancreas.
    Rao GJ; Nadler HL
    Pediatr Res; 1974 Jun; 8(6):684-6. PubMed ID: 4838499
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4.
    Dumenco LL; Everson B; Culp LA; Ratnoff OD
    J Lab Clin Med; 1988 Sep; 112(3):394-400. PubMed ID: 3045234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The secondary structure of human Hageman factor (factor XII) and its alteration by activating agents.
    McMillin CR; Saito H; Ratnoff OD; Walton AG
    J Clin Invest; 1974 Dec; 54(6):1312-22. PubMed ID: 4373492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High prekallikrein levels during pregnancy.
    Marcel GA; Caspar C; Sabatier C; Gautray J; Schirar A
    Pathol Biol (Paris); 1975 Dec; 23 suppl():66-8. PubMed ID: 772561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of adrenaline on the contact phase of blood coagulation].
    Ratmanova VI
    Fiziol Zh SSSR Im I M Sechenova; 1976 May; 62(5):699-702. PubMed ID: 1278548
    [No Abstract]   [Full Text] [Related]  

  • 39. Relationship between kallikrein release and factor XII in normal persons and carriers of the Hageman trait.
    Torres M; Ercoreca L; Lucia JF; Giralt M; Raichs A
    Thromb Haemost; 1979 Dec; 42(4):1286-8. PubMed ID: 261563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
    Saito H; Ratnoff OD
    J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.